Effect of Mild Sedation and Analgesia on Radial Artery Cannulation in Novice Residents
NCT ID: NCT05863455
Last Updated: 2024-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
108 participants
INTERVENTIONAL
2023-05-17
2024-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mild sedation and analgesia
Intravenous injection of 0.1ug/kg sufentanil and 0.03mg/kg midazolam for sedation and analgesia before radial artery cannulation.
mild sedation and analgesia
Intravenous injection of 0.1ug/kg sufentanil and 0.03mg/kg midazolam for sedation and analgesia before radial artery cannulation
control
Intravenous injection of an equivalent volume of saline before radial artery cannulation.
control
ntravenous injection of an equivalent volume of saline before radial artery cannulation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mild sedation and analgesia
Intravenous injection of 0.1ug/kg sufentanil and 0.03mg/kg midazolam for sedation and analgesia before radial artery cannulation
control
ntravenous injection of an equivalent volume of saline before radial artery cannulation.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged \>20years
* ASA physical status of 1-3
* BMI 18-28kg/m2
* All patients agreed to participate in this study at the time of recruitment and signed an informed consent form.
Exclusion Criteria
* infection at the puncture site
* coagulation disorders; arterial diseases (such as Raynaud's disease or thromboangiitis obliterans)
* use of vasoactive drugs within 30 minutes before measurement during the study
* patients with arterial abnormalities and bends; hemorrhagic shock
* arterial atherosclerosis; radial artery puncture within the past 30 days
* chronic use of opioid or benzodiazepine drugs
* and known allergies or adverse reactions to benzodiazepines or opioids.
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Affiliated Hospital of Jiaxing University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Qing-he Zhou
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qinghe Zhou
Role: PRINCIPAL_INVESTIGATOR
Affiliated Hospital of Jiaxing University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Affiliated Hospital of Jiaxing University
Jiaxing, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Xi YZ, Li ZP, Zhou QH. Effect of mild sedation and analgesia on radial artery cannulation in novice residents: a prospective, randomized controlled trial. BMC Med Educ. 2024 Dec 21;24(1):1515. doi: 10.1186/s12909-024-06568-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-KY-297
Identifier Type: -
Identifier Source: org_study_id